There are 859 resources available
Introduction to the session and presentation of case/condition
Presenter: Marniza Saad
Session: Transition from hormone-sensitive to castration-resistant prostate cancer
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: Samuel Ow
Session: Management of central nervous system (CNS) disease in HER2+ in metastatic breast cancer
Resources:
Slides
Webcast
Leveraging the molecular biology of hepatocellular carcinoma (HCC) in optimising response to immunotherapy
Presenter: Stephen Chan
Session: Leveraging the molecular biology of gastrointestinal cancers for optimal benefit from immunotherapeutic approaches
Resources:
Slides
Webcast
Current status of SBRT in lung cancer
Presenter: Yasuhio Nagata
Session: Radiation oncology session 2 - Radiotherapy 2023: Optimal management and future
Resources:
Slides
Webcast
Antibody drug conjugates (ADCs)
Presenter: Noemi Reguart Aransay
Session: Non-small cell lung cancer (NSCLC) treatment options after chemo-immuno failure
Resources:
Slides
Webcast
First-line treatment selection in metastatic hormone-sensitive prostate cancer (mHSPC)
Presenter: Deborah Mukherji
Session: Transition from hormone-sensitive to castration-resistant prostate cancer
Resources:
Slides
Webcast
Imaging modalities to diagnose and assess CNS disease in metastatic breast cancer: Which to choose and when
Presenter: Gabriel Garcia
Session: Management of central nervous system (CNS) disease in HER2+ in metastatic breast cancer
Resources:
Slides
Webcast
Enhancing immunotherapy responsiveness in squamous versus adenocarcinoma based on molecular biology (focus on primarily esophageal cancer)
Presenter: Brian Henick
Session: Leveraging the molecular biology of gastrointestinal cancers for optimal benefit from immunotherapeutic approaches
Resources:
Slides
Webcast
State of the art of radiotherapy in advanced prostate cancer
Presenter: Vedang Murthy
Session: Radiation oncology session 2 - Radiotherapy 2023: Optimal management and future
Resources:
Slides
Webcast
Progression of the case
Presenter: Marniza Saad
Session: Transition from hormone-sensitive to castration-resistant prostate cancer
Resources:
Slides
Webcast